Access
To read this story in full you will need to login or make a payment (see right).
News
Nature 425, 225 (18 September 2003) | doi:10.1038/425225a
Drug companies snub antibiotics as pipeline threatens to run dry
Tom Clarke
Major drug companies are pulling out of antibiotic development — and their timing couldn't be worse, a leading meeting on infectious disease was told this week.Speakers at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago said that many firms, such as Roche and Eli Lilly, are turning away from antibiotics to concentrate on treatments for chronic illness instead.
To read this story in full you will need to login or make a payment (see right).